SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 28.1 EUR 1.59% Market Closed
Market Cap: 4.2B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

SCHOTT Pharma AG & Co KgaA
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCHOTT Pharma AG & Co KgaA
Operating Expenses Peer Comparison

Comparables:
E
EVT
GXI

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Operating Expenses
-€145.3m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Evotec SE
XETRA:EVT
Operating Expenses
-€199.1m
CAGR 3-Years
-32%
CAGR 5-Years
-34%
CAGR 10-Years
-14%
Gerresheimer AG
XETRA:GXI
Operating Expenses
-€377.2m
CAGR 3-Years
-11%
CAGR 5-Years
-8%
CAGR 10-Years
-5%

See Also

What is SCHOTT Pharma AG & Co KgaA's Operating Expenses?
Operating Expenses
-145.3m EUR

Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Operating Expenses amounts to -145.3m EUR.

What is SCHOTT Pharma AG & Co KgaA's Operating Expenses growth rate?
Operating Expenses CAGR 3Y
-11%

Over the last year, the Operating Expenses growth was -13%. The average annual Operating Expenses growth rates for SCHOTT Pharma AG & Co KgaA have been -11% over the past three years .

Back to Top